|
LTRN Lantern Pharma Inc 1763950 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-3,329,171.00 |
| Balance Sheet |
|
Current Assets
|
$7,057,260.00 |
|
Assets
|
$7,223,067.00 |
|
Current Liabilities
|
$3,777,366.00 |
|
Liabilities
|
$3,777,366.00 |
|
Equity
|
$3,445,701.00 |
|
Shares Out
|
11254697.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,772,627.00 |
|
Investing Cash Flow
|
$4,250,000.00 |
| Market Analysis |
Market Cap
|
$29,824,947.05 |
|
Price
|
$2.68 |
|
BVPS
|
0.31 |
|
PB
|
8.55 |
|
EPS
|
-0.30 |
|
FCF
|
$-3,774,342.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:40 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:39 |
|
| Apr |
May |
Jun |
| 2026-03-30 |
-1.57 |
|
|
2026-05-15 |
-0.30 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-13 |
-0.40 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-0.39 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LTRN documents filed with the SEC.
LTRN Filings
Clear
